Free Trial

VanEck Biotech ETF (BBH) News Today

$164.44
-3.61 (-2.15%)
(As of 05/28/2024 ET)
Why Invest in Biotech Stocks (BBH)
One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccines
BBH: A Solid Way To Play A Comeback In Biotech
BBH ETF Stock Price History
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 82.4%
VanEck Biotech ETF (NASDAQ:BBH - Get Free Report) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totalling 6,200 shares, an increase of 82.4% from the August 15th total of 3,400 shares. Based on an average trading volume of 6,400 shares, the days-to-cover ratio is currently 1.0 days.
Quintet Private Bank Europe S.A. Takes Position in VanEck Biotech ETF (NASDAQ:BBH)
Quintet Private Bank Europe S.A. bought a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 4,004 shares of the compa
LPL Financial LLC Has $7.81 Million Stock Position in VanEck Biotech ETF (NASDAQ:BBH)
LPL Financial LLC lessened its stake in VanEck Biotech ETF (NASDAQ:BBH - Free Report) by 2.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,159 shares of the company's stock after selling 1,284 shares du
Tower Research Capital LLC TRC Boosts Stock Position in VanEck Biotech ETF (NASDAQ:BBH)
Tower Research Capital LLC TRC grew its stake in VanEck Biotech ETF (NASDAQ:BBH - Free Report) by 38.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,051 shares of the company's stock after purcha
VanEck ETFs
Miller Investment Management LP Grows Position in VanEck Biotech ETF (NASDAQ:BBH)
Miller Investment Management LP raised its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 117.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,623 shares of the company's stock after acquiri
Commerce Bank Takes Position in VanEck Biotech ETF (NASDAQ:BBH)
Commerce Bank acquired a new position in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,300 shares of the company's stock, valued at approximately $
Chevy Chase Trust Holdings LLC Purchases New Holdings in VanEck Biotech ETF (NASDAQ:BBH)
Chevy Chase Trust Holdings LLC purchased a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,741 shares of the company's stoc
Van Eck Biotech Etf $BBH Trading Report
Janney Montgomery Scott LLC Sells 1,050 Shares of VanEck Biotech ETF (NASDAQ:BBH)
Janney Montgomery Scott LLC trimmed its holdings in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 13.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,520 shares of the company's stock after selling 1,050 shares during the
BBH VanEck Biotech ETF
Kestra Advisory Services LLC Lowers Holdings in VanEck Biotech ETF (NASDAQ:BBH)
Kestra Advisory Services LLC reduced its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 8.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,353 shares of the company's stock after selling 1,668 shares during the
Cyndeo Wealth Partners LLC Takes Position in VanEck Biotech ETF (NASDAQ:BBH)
Cyndeo Wealth Partners LLC acquired a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,300 shares of the company's sto
Aspiriant LLC Has $1.21 Million Stock Position in VanEck Biotech ETF (NASDAQ:BBH)
Aspiriant LLC boosted its stake in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 63.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 7,583 shares of the company's stock after buying an additional 2,955 shares during the period. Aspirian
VanEck Biotech ETF BBH
American Trust Takes $368,000 Position in VanEck Biotech ETF (NASDAQ:BBH)
American Trust purchased a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,328 shares of the company's stock, valued at approximately $368,000. American Tru
VanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 74.1% in February
VanEck Biotech ETF (NASDAQ:BBH - Get Rating) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 2,200 shares, a decrease of 74.1% from the February 13th total of 8,500 shares. Based on an average daily volume of 11,000 shares, the days-to-cover ratio is currently 0.2 days.
MML Investors Services LLC Buys New Stake in VanEck Biotech ETF (NASDAQ:BBH)
MML Investors Services LLC bought a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,833 shares of the company's stock, valued at approximately $399,000. M
Wealthspire Advisors LLC Decreases Stake in VanEck Biotech ETF (NASDAQ:BBH)
Wealthspire Advisors LLC lowered its position in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 68.6% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 1,542 shares of the company's stock after selling 3,365 shares during the period. Weal
Tower Research Capital LLC TRC Sells 2,422 Shares of VanEck Biotech ETF (NASDAQ:BBH)
Tower Research Capital LLC TRC trimmed its position in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 47.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,683 shares of the company's stock after selling
First Republic Investment Management Inc. Acquires 10,515 Shares of VanEck Biotech ETF (NASDAQ:BBH)
First Republic Investment Management Inc. lifted its holdings in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 514.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,558 shares of the company'
Raymond James Financial Services Advisors Inc. Grows Stake in VanEck Biotech ETF (NASDAQ:BBH)
Raymond James Financial Services Advisors Inc. lifted its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 11.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,654 shares of the
Janney Montgomery Scott LLC Lowers Stock Holdings in VanEck Biotech ETF (NASDAQ:BBH)
Janney Montgomery Scott LLC lowered its holdings in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 7.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,570 shares of the company's stock aft
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 106.6%
VanEck Biotech ETF (NASDAQ:BBH - Get Rating) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 12,600 shares, an increase of 106.6% from the November 15th total of 6,100 shares. Based on an average daily volume of 12,800 shares, the days-to-cover ratio is presently 1.0 days.
Biotech Finally Getting Its Groove Back
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 182.1%
VanEck Biotech ETF (NASDAQ:BBH - Get Rating) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 31,600 shares, an increase of 182.1% from the October 15th total of 11,200 shares. Based on an average trading volume of 12,900 shares, the short-interest ratio is currently 2.4 days.
IBB iShares Biotechnology ETF
VanEck Biotech ETF (NASDAQ:BBH) Short Interest Up 41.3% in September
VanEck Biotech ETF (NASDAQ:BBH - Get Rating) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 11,300 shares, an increase of 41.3% from the August 31st total of 8,000 shares. Based on an average daily volume of 15,100 shares, the short-interest ratio is presently 0.7 days.
Consolidation Case for Biotech ETF BBH
VanEck Biotech ETF (BBH)
Biotech Bounce-Back Could Be Durable
Short Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 44.9%
VanEck Biotech ETF (NASDAQ:BBH - Get Rating) saw a large drop in short interest in July. As of July 31st, there was short interest totalling 8,700 shares, a drop of 44.9% from the July 15th total of 15,800 shares. Based on an average trading volume of 24,900 shares, the short-interest ratio is presently 0.3 days.
Biotech Rebound Could Finally Be Afoot
Bank on BBH for Surprising Protection
Get VanEck Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

The #1 Crypto That You Don’t Own… Yet (Ad)

There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.

Click here for all the details…

BBH Media Mentions By Week

BBH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BBH
News Sentiment

0.92

0.72

Average
Finance
News Sentiment

BBH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BBH Articles
This Week

3

0

BBH Articles
Average Week

Get VanEck Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BBH) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners